The Evidence Stack: We Benchmarked our ML Powered Research Synthesis Platform Against the Most Studied Drugs on Earth
singularitydynamics.substack.com · 2,432 words · saved by 1 readers
Periscopic Labs · March 2026
We’re opening the waitlist for Discovery Synth today. If you work in Biotech, Pharma, Clinical research, Health Economics or Health technology - or if you’re an ML researcher or engineer who wants to work on problems that actually matter - we’d love to hear from you. → Join the waitlist at Discovery Synth → Full benchmark report at Benchmark-Discovery-Synth It’s 2:00 AM. A researcher at a mid-size biotech is sitting in front of 47 open browser tabs - PubMed, ClinicalTrials.gov, three Cochrane reviews, a half-downloaded PDF from NEJM, a UniProt page she opened four hours ago and hasn’t…
related reading
- Rebuild Biotech for the AI Era | Benchlingbenchling.com
- The ML drug discovery startup trying really, really hard to not cheat (Leash Bio)owlposting.com
- The Business of Extracting Knowledge from Academic Publicationsmarkusstrasser.org
- Generative ML in chemistry is bottlenecked by synthesisowlposting.com
- How we built our lab in 30 days — Bindwellbindwell.com
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- the drug landscapegenome-browser-eight.vercel.app
- AI-Powered Drug Discovery Platform | Deep Origindeeporigin.com
- Warpspeed — Forecastswarpspeed.sh
- So where are we with deep learning for biochem?ladanuzhna.xyz
- AI Versus Eroom's Lawsubstack.com
- TorchDrug: A Powerful and Flexible Machine Learning Platform for Drug Discoveryarxiv.org